From traditional Chinese medicine to rational cancer therapy
Top Cited Papers
- 31 August 2007
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 13 (8), 353-361
- https://doi.org/10.1016/j.molmed.2007.07.001
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Natural Products as Sources of New Drugs over the Last 25 YearsJournal of Natural Products, 2007
- Research priorities in traditional Chinese medicineBMJ, 2006
- A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemiaBritish Journal of Cancer, 2006
- The spindle assembly checkpoint: Preventing chromosome mis‐segregation during mitosis and meiosisFEBS Letters, 2006
- Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cellsLife Sciences, 2006
- Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinibCancer, 2005
- The Anti-Angiogenic Effect of SinomenineAngiogenesis, 2005
- Aristolochic acid (AA)‐DNA adduct as marker of AA exposure and risk factor for AA nephropathy‐associated cancerInternational Journal of Cancer, 2004
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003
- Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)The New England Journal of Medicine, 2000